DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Lewis Phillips GD et al.
Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate.
Cancer Res 2008;
68(22): 9280-90
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.